Clin2
NCT07396194Possibly a fitNot yet recruiting

Study for people with ankylosing spondylitis

Ankylosing Spondylitis

Part of Bones, joints & muscles clinical trials.

This trial is for people with ankylosing spondylitis (a type of arthritis that affects the spine) who are otherwise healthy. It may test a treatment to see if it helps control symptoms, whether your disease is active or stable.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
84 people
Ages
16 years to 80 years
Study type
Observational

Who can take part

  • You have been diagnosed with ankylosing spondylitis (active or stable) by a doctor.
  • You meet the international (ASAS) criteria for axial spondyloarthritis (your rheumatologist will confirm this).
  • You do not have any other autoimmune condition (like lupus, rheumatoid arthritis, or psoriasis).
  • You do not have a chronic illness such as diabetes, a long-term infection, cancer, or other serious health problem.
  • You can be male or female.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07261644Recruiting· Phase 3
Study of a new drug for active ankylosing spondylitis

This study tests a new medication (called 608) for adults with active ankylosing spondylitis (AS). It aims to see if the drug can reduce AS symptoms and improve quality of life.

Beijing, Beijing Municipality
NCT07166874Recruiting
Gluten-free diet for ankylosing spondylitis

This study looks at how a gluten-free diet affects people with ankylosing spondylitis (a type of arthritis that mainly affects the spine). You would eat no gluten (found in wheat, barley, and rye) for a period of time to see if it helps reduce symptoms.

Istanbul
NCT07534644Not yet recruiting· Phase 1/Phase 2
Stem cell treatment for active ankylosing spondylitis

This trial tests whether stem cells from umbilical cord can reduce pain and stiffness in people with ankylosing spondylitis (a disease causing spinal inflammation). You may qualify if you have active AS that hasn't responded well to standard treatments.

NCT07237568Recruiting· Phase 3
Testing LNK01001 for active ankylosing spondylitis

This trial tests a new oral medication called LNK01001 for adults with active ankylosing spondylitis. It aims to reduce pain, stiffness, and inflammation when standard NSAID treatments no longer help.

Beijing
NCT07632599Not yet recruiting· Phase 1
Stem cell therapy for ankylosing spondylitis inflammation

This trial tests whether stem cells from donated bone marrow can reduce inflammation and pain in ankylosing spondylitis, a condition that causes the spine to become stiff and inflamed. Researchers will monitor how safe and effective this treatment is for eligible patients.

Shenzhen, Guangdong
NCT01277419Recruiting
Study of new cases of several spine, joint, and eye diseases

This study enrolls people who have recently been diagnosed with certain inflammatory conditions affecting the spine, joints, or the eye. Researchers are looking to better understand how these illnesses start and how they may be linked, which could help guide future care.

Berlin

Hear when a new Ankylosing Spondylitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.